SCHOTT Pharma AG & Co. KGaA Income Statement

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Revenue	948.56	898.6	821.14	648.67	584.23
Revenue Growth (YoY)	8.64%	9.43%	26.59%	11.03%	-
Cost of Revenue	624.35	582.11	524.51	422.5	388.22
Gross Profit	324.2	316.49	296.64	226.17	196.01
Selling, General & Admin	125.88	122.68	110.78	92.5	89.63
Research & Development	26.89	26.82	23.53	22.29	23.58
Other Operating Expenses	-14.71	-4.23	-5.68	-3.12	-8.18
Operating Expenses	138.07	145.28	128.63	111.67	105.04
Operating Income	186.14	171.21	168.01	114.5	90.97
Interest Expense	-10.94	-6.66	-2.11	-1.19	-1.51
Interest & Investment Income	6.4	5.23	2.14	0.56	0.56
Earnings From Equity Investments	10.57	11.74	12.99	13.7	5.55
Currency Exchange Gain (Loss)	-15.49	2.71	-7.03	-1.45	0.45
Other Non Operating Income (Expenses)	-2.88	-4.55	-5.54	-3.26	-1.55
EBT Excluding Unusual Items	173.79	179.68	168.46	122.87	94.46
Merger & Restructuring Charges	-	-	-11.78	-	-
Gain (Loss) on Sale of Assets	0.39	0.39	1.51	0.3	0.72
Asset Writedown	-0.5	5.2	-	-	-
Pretax Income	174.21	185.8	158.29	123.28	95.3
Income Tax Expense	23.35	33.87	32.44	22.12	17.67
Earnings From Continuing Operations	150.86	151.93	125.85	101.17	77.63
Minority Interest in Earnings	-0.45	-0.09	-0.47	-0.41	-0.15
Net Income	150.41	151.84	125.38	100.75	77.48
Net Income to Common	150.41	151.84	125.38	100.75	77.48
Net Income Growth	5.38%	21.11%	24.44%	30.04%	-
Shares Outstanding (Basic)	151	151	151	151	151
Shares Outstanding (Diluted)	151	151	151	151	151
Shares Change (YoY)	0.26%	-	0.00%	-	-
EPS (Basic)	1.00	1.01	0.83	0.67	0.51
EPS (Diluted)	1.00	1.01	0.83	0.67	0.51
EPS Growth	5.11%	21.46%	24.08%	31.17%	-
Free Cash Flow	21.63	6.19	30.11	34.14	19.22
Free Cash Flow Per Share	0.14	0.04	0.20	0.23	0.13
Dividend Per Share	0.150	0.150	0.125	-	-
Dividend Growth	20.00%	20.00%	-	-	-
Gross Margin	34.18%	35.22%	36.13%	34.87%	33.55%
Operating Margin	19.62%	19.05%	20.46%	17.65%	15.57%
Profit Margin	15.86%	16.90%	15.27%	15.53%	13.26%
Free Cash Flow Margin	2.28%	0.69%	3.67%	5.26%	3.29%
EBITDA	246.97	223.06	211.8	150.94	124.7
EBITDA Margin	26.04%	24.82%	25.79%	23.27%	21.34%
D&A For EBITDA	60.84	51.85	43.79	36.44	33.73
EBIT	186.14	171.21	168.01	114.5	90.97
EBIT Margin	19.62%	19.05%	20.46%	17.65%	15.57%
Effective Tax Rate	13.40%	18.23%	20.49%	17.94%	18.54%

Source: S&P Capital IQ. Standard template. Financial Sources.